Unexpected sequences and structures of mtDNA required for efficient transcription from the first heavy-strand promoter

  1. Akira Uchida
  2. Divakaran Murugesapillai
  3. Markus Kastner
  4. Yao Wang
  5. Maria F Lodeiro
  6. Shaan Prabhakar
  7. Guinevere V Oliver
  8. Jamie J Arnold
  9. L James Maher
  10. Mark C Williams  Is a corresponding author
  11. Craig E Cameron  Is a corresponding author
  1. The Pennsylvaina State University, United States
  2. Northeastern University, United States
  3. The Pennsylvania State University, United States
  4. Mayo Clinic College of Medicine, United States

Abstract

Human mtDNA contains three promoters, suggesting a need for differential expression of the mitochondrial genome. Studies of mitochondrial transcription have used a reductionist approach, perhaps masking differential regulation. Here we evaluate transcription from light–strand (LSP) and heavy–strand (HSP1) promoters using templates that mimic their natural context. These studies reveal sequences upstream, hypervariable in the human population (HVR3), and downstream of the HSP1 transcription start site required for maximal yield. The carboxy–terminal tail of TFAM is essential for activation of HSP1 but not LSP. Images of the template obtained by atomic force microscopy show that TFAM creates loops in a discrete region, the formation of which correlates with activation of HSP1; looping is lost in tail–deleted TFAM. Identification of HVR3 as a transcriptional regulatory element may contribute to between–individual variability in mitochondrial gene expression. The unique requirement of HSP1 for the TFAM tail may enable its regulation by post–translational modifications.

Article and author information

Author details

  1. Akira Uchida

    Department of Biochemistry and Molecular Biology, The Pennsylvaina State University, University Park, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Divakaran Murugesapillai

    Department of Physics, Northeastern University, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Markus Kastner

    Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Yao Wang

    Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Maria F Lodeiro

    Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Shaan Prabhakar

    Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Guinevere V Oliver

    Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Jamie J Arnold

    Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. L James Maher

    Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Mark C Williams

    Department of Physics, Northeastern University, Boston, United States
    For correspondence
    ma.williams@northeastern.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3219-376X
  11. Craig E Cameron

    Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, United States
    For correspondence
    cec9@psu.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7564-5642

Funding

National Institute of General Medical Sciences (GM075965)

  • L James Maher

National Science Foundation (MCB-1243883)

  • Mark C Williams

Eberly Family Chair Endowment

  • Craig E Cameron

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2017, Uchida et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,518
    views
  • 345
    downloads
  • 33
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Akira Uchida
  2. Divakaran Murugesapillai
  3. Markus Kastner
  4. Yao Wang
  5. Maria F Lodeiro
  6. Shaan Prabhakar
  7. Guinevere V Oliver
  8. Jamie J Arnold
  9. L James Maher
  10. Mark C Williams
  11. Craig E Cameron
(2017)
Unexpected sequences and structures of mtDNA required for efficient transcription from the first heavy-strand promoter
eLife 6:e27283.
https://doi.org/10.7554/eLife.27283

Share this article

https://doi.org/10.7554/eLife.27283

Further reading

    1. Biochemistry and Chemical Biology
    Adrian CD Fuchs
    Research Article

    The protein ligase Connectase can be used to fuse proteins to small molecules, solid carriers, or other proteins. Compared to other protein ligases, it offers greater substrate specificity, higher catalytic efficiency, and catalyzes no side reactions. However, its reaction is reversible, resulting in only 50% fusion product from two equally abundant educts. Here, we present a simple method to reliably obtain 100% fusion product in 1:1 conjugation reactions. This method is efficient for protein-protein or protein-peptide fusions at the N- or C-termini. It enables the generation of defined and completely labeled antibody conjugates with one fusion partner on each chain. The reaction requires short incubation times with small amounts of enzyme and is effective even at low substrate concentrations and at low temperatures. With these characteristics, it presents a valuable new tool for bioengineering.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Joar Esteban Pinto Torres, Mathieu Claes ... Yann G-J Sterckx
    Research Article

    African trypanosomes are the causative agents of neglected tropical diseases affecting both humans and livestock. Disease control is highly challenging due to an increasing number of drug treatment failures. African trypanosomes are extracellular, blood-borne parasites that mainly rely on glycolysis for their energy metabolism within the mammalian host. Trypanosomal glycolytic enzymes are therefore of interest for the development of trypanocidal drugs. Here, we report the serendipitous discovery of a camelid single-domain antibody (sdAb aka Nanobody) that selectively inhibits the enzymatic activity of trypanosomatid (but not host) pyruvate kinases through an allosteric mechanism. By combining enzyme kinetics, biophysics, structural biology, and transgenic parasite survival assays, we provide a proof-of-principle that the sdAb-mediated enzyme inhibition negatively impacts parasite fitness and growth.